UK markets close in 8 hours 21 minutes

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1500-0.0300 (-1.38%)
At close: 04:00PM EDT
2.1500 0.00 (0.00%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.1800
Bid0.0000 x 4000
Ask0.0000 x 2900
Day's range2.0650 - 2.2500
52-week range2.0200 - 8.1300
Avg. volume2,651,954
Market cap271.988M
Beta (5Y monthly)0.77
PE ratio (TTM)N/A
EPS (TTM)-0.6410
Earnings date02 Nov 2022 - 07 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date09 Nov 2012
1y target est7.75
  • Zacks

    VAXART, INC. (VXRT) Reports Q2 Loss, Lags Revenue Estimates

    VAXART, INC. (VXRT) delivered earnings and revenue surprises of -9.52% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Motley Fool

    Could This Unknown Stock Beat Moderna in 2023?

    Vaxart (NASDAQ: VXRT) might just be gearing up to steal coronavirus vaccine market share from Moderna (NASDAQ: MRNA) in the next couple of years, making its investors wealthy in the process. The biotech's vaccine tablets could have a few advantages that Moderna's shots don't, including one in particular, that might be a public health holy grail at the moment. For Vaxart's stock to beat Moderna's next year, two things need to happen.

  • Motley Fool

    3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

    Vaxart (NASDAQ: VXRT) is working on a coronavirus vaccine candidate. Recently, Vaxart said its omicron-specific candidate and its original candidate both protected against the variant in preclinical tests. Of course, even if Vaxart is successful, the company will make it to market much later than bigger rivals.